POL vaccine buying item
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{up|Politics main page}} every week a new topic in the politics field {{tp|p=C7659892|t=2020. Impfdosen-Knappheit und Corona: ein neuer Stresstest?|pdf=|u…“) |
K |
||
| Zeile 5: | Zeile 5: | ||
{{tp|p=C7659892|t=2020. Impfdosen-Knappheit und Corona: ein neuer Stresstest?|pdf=|usr=023}} | {{tp|p=C7659892|t=2020. Impfdosen-Knappheit und Corona: ein neuer Stresstest?|pdf=|usr=023}} | ||
{{tp|p=C7719297|t=2020. We need to start thinking about promoting the demand uptake and equitable distribution of COVID-19 vaccines NOW!|pdf=|usr=023}} | {{tp|p=C7719297|t=2020. We need to start thinking about promoting the demand uptake and equitable distribution of COVID-19 vaccines NOW!|pdf=|usr=023}} | ||
| + | {{tp|p=33021168|t=2020. Facilitating Access to a COVID-19 Vaccine through Global Health Law.|pdf=|usr=019}} | ||
| + | {{tp|p=32883884|t=2020. An ethical framework for global vaccine allocation.|pdf=|usr=021}} | ||
| + | {{tp|p=33026758|t=2020. Framework for Equitable Allocation of COVID-19 Vaccine|pdf=|usr=020}} | ||
| + | {{tp|p=33052391|t=2020. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?|pdf=|usr=020}} | ||
| + | {{tp|p=33211542|t=2020. Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.|pdf=|usr=021}} | ||
Version vom 5. Januar 2021, 21:48 Uhr
| Politics main page |
every week a new topic in the politics field
C7659892 2020. Impfdosen-Knappheit und Corona: ein neuer Stresstest?
C7719297 2020. We need to start thinking about promoting the demand uptake and equitable distribution of COVID-19 vaccines NOW!
33021168 2020. Facilitating Access to a COVID-19 Vaccine through Global Health Law.
32883884 2020. An ethical framework for global vaccine allocation.
33026758 2020. Framework for Equitable Allocation of COVID-19 Vaccine
33052391 2020. Is It Lawful and Ethical to Prioritize Racial Minorities for COVID-19 Vaccines?
33211542 2020. Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.
